Rutika J. Mehta, MD, MPH, discusses the role of biomarkers in gastric cancer.
Rutika J. Mehta, MD, MPH, a medical oncologist specializing in gastrointestinal cancer at Moffitt Cancer Center, discusses the role of biomarkers in gastric cancer.
Biomarkers such as microsatellite instability, mismatch repair deficiency, HER2 status, PD-L1 status, and tumor mutational burden are of interest in the gastric cancer space, says Mehta.
Moreover, according to Mehta, all patients with metastatic disease should be molecularly profiled.
Additionally, if tissue is available, ordering next-generation sequencing may be beneficial in terms of treatment selection and identifying available clinical trials, Mehta concludes.